Published in Lancet on January 15, 1997
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas. Genome Biol (2008) 1.64
Principles of cancer screening: lessons from history and study design issues. Semin Oncol (2010) 1.52
Mechanisms of neuroblastoma regression. Nat Rev Clin Oncol (2014) 1.17
The prenatal origins of cancer. Nat Rev Cancer (2014) 1.09
Where should neuroblastoma mass screening go? Lancet (1997) 1.07
Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment. Pediatr Surg Int (2003) 0.99
Gene profiling of high risk neuroblastoma. World J Surg (2005) 0.94
Newborn urine screening programme in the province of Quebec: an update of 30 years' experience. J Inherit Metab Dis (2003) 0.93
Seeking Genomic Knowledge: The Case for Clinical Restraint. Hastings Law J (2013) 0.89
Dependence receptor UNC5D mediates nerve growth factor depletion-induced neuroblastoma regression. J Clin Invest (2013) 0.87
MRP1 gene expression level regulates the death and differentiation response of neuroblastoma cells. Br J Cancer (2001) 0.86
Inhibition of angiogenesis induces chromaffin differentiation and apoptosis in neuroblastoma. Am J Pathol (1999) 0.84
Long-term follow-up of the "wait and see" approach to localized perinatal adrenal neuroblastoma. World J Surg (2013) 0.84
Autoantibody signature differentiates Wilms tumor patients from neuroblastoma patients. PLoS One (2011) 0.79
Natural history of neuroblastoma found by mass screening. Lancet (1997) 0.78
Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma. PLoS One (2016) 0.75
Effectiveness of nationwide screening program for neuroblastoma in Japan. Glob J Health Sci (2014) 0.75
Natural history of diseases: Statistical designs and issues. Clin Pharmacol Ther (2016) 0.75
Neuroblastoma mass screening in children. Lancet (1997) 0.75
Lung cancer screening: promise and pitfalls. Semin Oncol Nurs (2008) 0.75
Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron (2000) 22.02
Residential exposure to magnetic fields and acute lymphoblastic leukemia in children. N Engl J Med (1997) 6.72
Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med (1996) 5.14
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol (1996) 5.09
Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst (2001) 4.69
Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol (2001) 4.56
Characterization of a component of the yeast secretion machinery: identification of the SEC18 gene product. Mol Cell Biol (1988) 3.74
Clinical description and roentgenologic evaluation of patients with Friedreich's ataxia. Can J Neurol Sci (1976) 3.69
Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes (1999) 3.68
Differences between respondents and nonrespondents in a multicenter community-based study vary by gender ethnicity. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. J Clin Epidemiol (1996) 3.49
A conditional sterile mutation eliminates surface components from Arabidopsis pollen and disrupts cell signaling during fertilization. Genes Dev (1993) 3.43
Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet (1994) 3.12
Relation of breast cancer with passive and active exposure to tobacco smoke. Am J Epidemiol (1996) 2.93
Neurological manifestations of intracranial dural arteriovenous malformations. J Neurosurg (1986) 2.72
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrob Agents Chemother (1984) 2.71
Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer (1995) 2.65
Map-based cloning of a gene controlling omega-3 fatty acid desaturation in Arabidopsis. Science (1992) 2.59
Occupational exposures of parents of children with acute nonlymphocytic leukemia: a report from the Childrens Cancer Study Group. Cancer Res (1989) 2.55
Student perceptions of methylphenidate abuse at a public liberal arts college. J Am Coll Health (2000) 2.52
Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States. Antimicrob Agents Chemother (1985) 2.47
Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation. Antimicrob Agents Chemother (1988) 2.45
Interaction forces between red cells agglutinated by antibody. II. Measurement of hydrodynamic force of breakup. Biophys J (1986) 2.43
Genome-wide mapping with biallelic markers in Arabidopsis thaliana. Nat Genet (1999) 2.43
Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children's Cancer Group. Am J Epidemiol (1997) 2.36
Association between childhood acute lymphoblastic leukemia and use of electrical appliances during pregnancy and childhood. Epidemiology (1998) 2.33
Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med (1991) 2.27
National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health (1997) 2.17
Identification and map position of YAC clones comprising one-third of the Arabidopsis genome. Plant J (1991) 2.17
Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy. J Neurosurg (1998) 2.17
A syndrome of congenital hyperinsulinism and hyperammonemia. J Pediatr (1997) 2.15
Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood (1994) 2.14
Characterization of a gene product (Sec53p) required for protein assembly in the yeast endoplasmic reticulum. J Cell Biol (1985) 1.97
Significance of hemorrhage into brain tumors: clinicopathological study. J Neurosurg (1987) 1.95
Alternative pathway therapy for urea cycle disorders: twenty years later. J Pediatr (2001) 1.88
Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992. J Pediatr Hematol Oncol (1997) 1.87
Links between passive smoking and disease: a best-evidence synthesis. A report of the Working Group on Passive Smoking. Clin Invest Med (1990) 1.87
Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res (2000) 1.86
Are children living near high-voltage power lines at increased risk of acute lymphoblastic leukemia? Am J Epidemiol (2000) 1.82
Household solvent exposures and childhood acute lymphoblastic leukemia. Am J Public Health (2001) 1.80
Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion. Ann Neurol (1997) 1.79
Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging. Arch Neurol (1987) 1.78
Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group. Cancer Res (1991) 1.77
Malignant neoplasms following bone marrow transplantation. Blood (1996) 1.76
Epidemiological characteristics of childhood acute lymphocytic leukemia. Analysis by immunophenotype. The Childrens Cancer Group. Leukemia (1994) 1.76
Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia. JAMA (1994) 1.76
Mechanical bowel preparation for elective colorectal surgery. A prospective, randomized, surgeon-blinded trial comparing sodium phosphate and polyethylene glycol-based oral lavage solutions. Dis Colon Rectum (1997) 1.75
Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children. Paediatr Drugs (2001) 1.74
Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys (1998) 1.72
Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype. Am J Med Genet (2000) 1.71
Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol (1999) 1.70
Absence of p53 gene mutations in primary neuroblastomas. Cancer Res (1993) 1.69
Trends in cancer incidence among children in the U.S. Cancer (1996) 1.69
Spinal cord concussion. J Neurosurg (1990) 1.68
Product of SEC53 is required for folding and glycosylation of secretory proteins in the lumen of the yeast endoplasmic reticulum. J Biol Chem (1987) 1.67
A comprehensive multiattribute system for classifying the health status of survivors of childhood cancer. J Clin Oncol (1992) 1.66
Congenital abnormalities in children with acute leukemia: a report from the Children's Cancer Group. J Pediatr (1998) 1.65
Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med (1988) 1.65
Validation of self-reported complications by bone marrow transplantation survivors. Bone Marrow Transplant (2000) 1.64
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia (2003) 1.64
Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project. Pediatrics (1990) 1.64
Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transplant (2006) 1.63
Epidemiology of childhood leukemia, with a focus on infants. Epidemiol Rev (1994) 1.63
The CER3 gene of Arabidopsis thaliana is expressed in leaves, stems, roots, flowers and apical meristems. Plant J (1996) 1.62
Fatal hyperammonemia following orthotopic lung transplantation. Gastroenterology (1997) 1.61
Diabetic ketoacidosis. A rare complication of gestational diabetes. Diabetes Care (1992) 1.60
Insulin resistance syndrome in childhood: associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors. J Pediatr (2001) 1.59
ADR1-mediated regulation of ADH2 requires an inverted repeat sequence. Mol Cell Biol (1986) 1.57
International collaboration is feasible in trials for rare conditions: the EURAMOS experience. Cancer Treat Res (2009) 1.56
Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop Relat Res (1991) 1.56
Childhood cancer in the United States. A geographical analysis of cases from the Pediatric Cooperative Clinical Trials groups. Cancer (1996) 1.56
Clinical spectrum of succinic semialdehyde dehydrogenase deficiency. Neurology (2003) 1.54
Further evidence that the KIAA0319 gene confers susceptibility to developmental dyslexia. Mol Psychiatry (2006) 1.54
Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group. Headache (1998) 1.53
Maternal reproductive history and birth characteristics in childhood acute lymphoblastic leukemia. Cancer (1991) 1.53
Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryoprecipitate. Can Med Assoc J (1983) 1.52
Proceedings of a consensus conference for the management of patients with urea cycle disorders. J Pediatr (2001) 1.51
Association of HTLV-III antibodies and cellular immune status of hemophiliacs. N Engl J Med (1984) 1.51
Seasonal variations in the diagnosis of childhood cancer in the United States. Br J Cancer (1999) 1.50
Epstein-Barr virus polymorphic B-cell lymphoma associated with leukemia and with congenital immunodeficiencies. J Clin Oncol (1990) 1.48
Long-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence. Neurogastroenterol Motil (2014) 1.48
Molecular cloning and characterization of the CER2 gene of Arabidopsis thaliana. Plant J (1996) 1.47
Persistence and possible progression of a pelvic neuroblastoma detected by mass screening during 19 months. Am J Pediatr Hematol Oncol (1994) 1.47
The changing clinical presentation of complete molar pregnancy. Obstet Gynecol (1995) 1.47
Modified stereotactic insertion of the Ommaya reservoir. Technical note. J Neurosurg (2000) 1.46
Control selection using random digit dialing for cases of childhood cancer. Am J Epidemiol (1984) 1.46
Agent-based computational modeling of wounded epithelial cell monolayers. IEEE Trans Nanobioscience (2004) 1.45
Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Med Pediatr Oncol (2000) 1.45
Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Clin Oncol (1993) 1.45
Prognostic features of Ewing sarcoma on plain radiograph and computed tomography scan after initial treatment. A Pediatric Oncology Group study (8346) Cancer (1993) 1.44
Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial. J Pediatr (1996) 1.44